General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0YHWQY
ADC Name
RC-248
Synonyms
RC-248; RC 248; RC248
   Click to Show/Hide
Organization
RemeGen Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Lung cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
Undisclosed